Scarica l'app Stockscreener
1.43
2.88%
0.04
Pre-mercato:
1.42
-0.01
-0.70%
Tiziana Life Sciences Ltd Borsa (TLSA) Ultime notizie
TLSA SEC FilingsTiziana Life Sciences Ltd Com 10-K, 10-Q, 8-K Forms - Stock Titan
Tiziana Life Sciences | 20-F: Registration statement / Annual report / Transition report - Moomoo
Tiziana Life Sciences (TLSA) posts 2025 loss and faces going concern risk - Stock Titan
Tiziana Life Sciences Delays Annual 20-F Filing - TipRanks
Tiziana (TLSA) Stock: In-Depth Look (Mini Selloff) 2026-04-23Growth Investing - Newser
Wall Street Zen Downgrades Tiziana Life Sciences (NASDAQ:TLSA) to Sell - MarketBeat
Tiziana (TLSA) Stock Large Cap Focus (Hovering) 2026-04-16Most Discussed Stocks - Cổng thông tin điện tử Tỉnh Sơn La
Small cap wrap: 1911 Gold, Sona Nanotech, Tiziana Life Sciences, Gunnison Copper… - Proactive financial news
Tiziana Life Sciences (TLSA) Unveils Promising Preclinical Findi - GuruFocus
symbol__ Stock Quote Price and Forecast - CNN
Tiziana says intranasal drug shows potential to ease Long COVID “brain fog” - Yahoo! Finance Canada
Tiziana reports preclinical data on intranasal foralumab for Long COVID - Investing.com
Tiziana reports preclinical data on intranasal foralumab for Long COVID By Investing.com - Investing.com UK
Tiziana Life Sciences Announces Publication of Positive Data Demonstrating Intranasal Anti-CD3 Antibody Attenuates Long COVID Neuroinflammation and Improves Cognitive Function - The Manila Times
A nasal antibody cut brain inflammation in a Long COVID mouse study - Stock Titan
Tiziana Life Sciences (Nasdaq: TLSA) reports promising Long COVID preclinical results - Stock Titan
Market movers: Tesla, Wells Fargo, Lucid Group, Tiziana Life Sciences, Trillion Energy… - Proactive financial news
Tiziana Life Sciences’ Intranasal Foralumab MSA Trial Highlighted in Late-Breaking Poster at 7th World Parkinson Congress - TipRanks
Tiziana Life Sciences Announces Late Breaking Poster Accepted for Presentation at the 7th World Parkinson Congress - The Manila Times
Tiziana Life Sciences (TLSA) highlights Phase 2a intranasal foralumab MSA trial at World Parkinson Congress - Stock Titan
Tiziana Life Sciences to present Phase 2a MSA study at World Parkinson Congress - Proactive financial news
Tiziana Life Sciences Ltd. - Via Ritzau
Can Tiziana (TLSA) Stock Recover Now | Price at $1.24, Down 1.59%Fast Rising Picks - Newser
Aug Setups: What is the Moat Score of BlackRock Virginia Municipal Bond Trust2026 Pullback Review & Stock Timing and Entry Methods - baoquankhu1.vn
Swing Trade: Can Tiziana Life Sciences Ltd maintain its current growth ratePortfolio Gains Report & Consistent Return Investment Signals - baoquankhu1.vn
Downgrade Watch: Is Tiziana Life Sciences Ltd a cyclical or defensive stockMarket Risk Analysis & Reliable Entry Point Alerts - baoquankhu1.vn
TLSA Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Tiziana Life Sciences (NASDAQ:TLSA) Trading 6.8% HigherHere's What Happened - MarketBeat
Market movers: Nike, RH, Tiziana Life Sciences, Eli Lilly… - Proactive financial news
Tiziana Life Sciences Stock Jumps As Positive Preclinical Fuels Momentum - Benzinga
Tiziana Announces Data Showing Nasal Anti-CD3 Improves Cognition Associated with Aging - Bitget
Tiziana Life Sciences reports positive preclinical findings for intranasal anti-CD3 therapy in brain aging - Proactive financial news
Tiziana Life Sciences Reports Positive Preclinical Data for Nasal Anti-CD3 in Age-Related Cognitive Decline - TipRanks
Tiziana Life Sciences (NASDAQ: TLSA) posts positive nasal anti-CD3 data in aging model - Stock Titan
Tiziana Life Sciences Announces Data Showing Nasal Anti-CD3 Improves Cognition Associated with Aging - marketscreener.com
Volume Report: What are the future prospects of Tiziana Life Sciences LtdInflation Watch & Real-Time Market Sentiment Alerts - baoquankhu1.vn
Update Report: Does Tiziana Life Sciences Ltd outperform in volatile marketsQuarterly Trade Report & Risk Managed Investment Signals - baoquankhu1.vn
Aug Outlook: Does Tiziana Life Sciences Ltd offer margin of safety2026 Chart Watch & Safe Capital Allocation Plans - baoquankhu1.vn
If You Invested $1,000 in Tiziana Life Sciences Ltd Com (TLSA) - Stock Titan
Tiziana Life Sciences Ltd: Fundamental Analysis and Financial Ratings | 0RP | BMG889121031 - marketscreener.com
Macro Review: Is Tiziana Life Sciences Ltd stock a good dividend stock2026 Retail Activity & Verified Swing Trading Watchlists - baoquankhu1.vn
Large TLSA stake reported by director Gabriele M. Cerrone on Form 3 - Stock Titan
Macro Review: Is Tiziana Life Sciences Ltd subject to activist investor interest2026 Closing Moves & Weekly Sector Rotation Insights - baoquankhu1.vn
Forecast Cut: Can Tiziana Life Sciences Ltd maintain its current growth rate2026 Big Picture & Fast Moving Stock Watchlists - baoquankhu1.vn
Price Action: Can Tiziana Life Sciences Ltd be recession proofTrade Risk Report & High Accuracy Investment Signals - baoquankhu1.vn
TLSA Earnings History & Surprises | EPS & Revenue Results | TIZIANA LIFE SCIENCES LTD (NASDAQ:TLSA) - ChartMill
Tiziana Life Sciences (NASDAQ:TLSA) Stock Price Down 4.4%Should You Sell? - MarketBeat
Tiziana Life Sciences (TLSA) Stock Analysis Report | Financials & Insights - Benzinga Japan
Whats next for Tiziana Life Sciences Ltd stockAnalyst Upgrade & Real-Time Volume Trigger Notifications - baoquankhu1.vn
New Highs: Can Tiziana Life Sciences Ltd expand its profit margins2026 Sector Moves & Fast Gaining Stock Reports - baoquankhu1.vn
Aug Macro: Is Tiziana Life Sciences Ltd a stock for growth or value investorsMarket Performance Summary & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn
Day Trade: Can Tiziana Life Sciences Ltd maintain its current growth rate2025 Volume Leaders & Momentum Based Trading Ideas - baoquankhu1.vn
Market movers: Circle Internet Group, Tiziana Life Sciences, Cava, Lowe’s… - Proactive Investors
Tiziana reports biomarker gains for nasal MS therapy in progressive disease - Yahoo
Tiziana Life Sciences PLC (TLSA) announces new biomarker data - Bitget
Tiziana Life Sciences Posts Positive Biomarker Data for Intranasal Foralumab in Progressive MS - TipRanks
Tiziana Life Sciences Announces New Biomarker Data Showing Nasal Foralumab Downregulates CSF Inflammation, Upregulates Neuroprotective Pathways, and Correlates with Reduced Microglial Activation on PET Scans in na-SPMS Patients with PIRA - The Manila Times
New foralumab biomarker data in na-SPMS from Tiziana (Nasdaq: TLSA) - Stock Titan
0.14%
0.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):